By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Plexxikon Inc. 

91 Bolivar Drive

Berkeley  California  94710  U.S.A.
Phone: 510-647-4000 Fax: 510-548-8014



Start Up

Company News
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer 10/19/2016 5:47:33 AM
FDA Approves Daiichi Sankyo, Plexxikon's Cobimetinib In Combination With Zelboraf for Advanced Melanoma Patients 11/11/2015 6:24:35 AM
Daiichi Sankyo and Bay Area’s Plexxikon Inc. Win Breakthrough Tag for Pexidbartini 10/30/2015 9:30:58 AM
Daiichi Sankyo, Plexxikon Inc.'s Rare Disease Drug Shows Promise in Phase I Study 7/30/2015 5:58:15 AM
Plexxikon Inc. And Merck & Co. (MRK) To Collaborate On Combination Study Evaluating Investigational Immuno-Oncology Regimen 5/7/2015 10:19:38 AM
Plexxikon Inc. And Quantumleap Healthcare Collaborative Announce Selection Of PLX3397 For I-SPY 2 TRIAL In Breast Cancer 12/11/2014 8:00:33 AM
OncoSec Medical Inc. And Plexxikon Inc. Collaborate To Explore Combination Immunotherapy In Preclinical Tumor Studies 11/18/2014 12:35:42 PM
Plexxikon Inc. Announces Promising Preliminary PLX3397 Phase 1 Extension Data In Patients With Pigmented Villonodular Synovitis (PVNS) 5/15/2014 9:58:15 AM
Plexxikon Inc. Announces PLX3397 Data Presentations At American Society of Clinical Oncology 2014 Annual Meeting 5/15/2014 8:05:23 AM
Plexxikon Inc. Taps New CEO, COO 5/31/2013 8:43:22 AM